two
fraction
herp
simplex
viru
glycoprotein
gc
isol
character
mean
immunosorbentpurif
monoelon
antibodi
gc
helix
pomatia
leetin
hpa
affin
chromatographi
per
cent
glyeoprotein
gc
popul
demonstr
affin
lectin
compat
presenc
nacetylgalactosamin
termin
sugar
oligosaccharid
hpabind
popul
gc
appear
two
electrophoret
band
lower
molecular
weight
nonbind
gc
gc
subfract
without
affin
hpa
subject
treatment
aim
desialyl
carbohydr
moieti
per
cent
initi
nonreact
fraction
gc
becam
reactiv
hpa
treatment
suggest
mask
penultim
nacetylgalactosamin
sialic
acid
main
reason
lack
hpa
affin
result
treatment
alkalin
na
demonstr
presenc
oligosaccharidepeptidc
linkag
sensit
elimin
suggest
oglycosid
type
linkag
subfraet
gc
demonstr
affin
hpa
well
gc
devoid
hpa
bind
capac
reveal
affin
con
therefor
nglycosid
well
oglycosid
link
oligosaceharid
seem
present
one
glycoprotein
basi
result
present
assum
glycosyl
hsv
glyeoprotein
gc
may
lead
least
two
popul
gtyeoprotein
gc
one
termin
nacetylgalactosamin
residu
oligosaccharid
tink
polypeptid
without
affinityfor
hpa
howev
popul
gc
contain
similar
proport
oligosaccharid
high
olofsso
et
al
mannos
complex
type
nglycosid
carbohydratepeptid
linkag
indic
affin
con
known
glycoprotein
envelop
virus
contain
high
mannos
complex
type
ohgosaccharid
link
polypeptid
via
nglycosid
linkag
asparagin
naeetylglueosamin
glcnac
condit
tunicamyein
tm
inhibit
gtycosyl
virusinfect
cell
aberr
polypeptid
form
result
loss
viral
infect
accord
prevail
concept
main
function
nglycosid
oligosaecharid
stabil
polypeptid
conform
loss
infect
caus
indirectli
absenc
oligosaccharid
due
secondari
event
increas
sensit
intracellutar
proteolyt
degrad
unspecif
aggreg
underglycosyl
viral
glycoprotein
found
typespecif
glycoprotein
gc
herp
simplex
viru
type
contain
oligosaccharid
affin
nacetylgalactosaminebind
helix
pomatia
lectin
iipa
like
oligosaceharid
constitu
tte
hpabind
hsv
glyeoprotein
link
peptid
via
bond
naeetylgalaetosamin
galnac
serin
threonin
peptid
oglycosid
linkag
hsv
vaecinia
coronaviru
glycoprotein
describ
recent
tempt
compar
hpabind
iisv
gtycoprotein
sever
biolog
highli
activ
glyeoeonjug
blood
group
substanc
lymphocyt
differenti
antigen
also
demonstr
hpabind
activ
type
antigen
like
carbohydr
mediat
biolog
activ
phenomenon
contrast
less
specif
biolog
signific
nglycosid
oligosaceharid
recent
function
call
stagespecif
differenti
antigen
block
addit
compet
carbohydr
hapten
thu
hpabind
oligosaccharid
hsv
glyeoprotein
might
constitut
carbohydr
structur
defin
biolog
signific
probabl
recognit
structur
present
studi
distribut
iipabind
activ
among
iisv
glyeoprotein
investig
found
subfraet
gc
contain
hpabind
oligosaccharid
fraetion
contain
oligosaeeharid
without
affin
itpa
prototyp
viru
f
propag
veio
cell
maintain
monolay
cultur
minim
essenti
medium
mem
supplement
per
cent
foetm
calf
serum
fc
hfem
ts
gener
gift
dr
buehan
univers
birmingham
england
mutang
defect
gb
nonpermiss
temperatur
use
marker
ga
gb
monoclon
antibodi
ttybridoma
cell
produc
previous
describ
aseit
prepar
contain
monoelonm
antibodi
glycoprotein
gc
gagb
gd
tii
use
v
e
r
n
l
e
r
cell
grown
cm
e
tissu
cultur
flask
cell
infect
w
h
use
u
l
p
l
c
infect
p
f
u
c
e
l
l
n
v
l
u
e
ml
e
c
n
n
n
g
per
cent
fc
h
u
r
r
p
n
c
h
e
viru
aspir
n
h
e
cell
overlay
hour
postinfeet
b
h
e
n
ml
e
w
h
per
cent
fc
n
ciml
e
u
glucosamin
specif
c
v
mcimmol
e
r
h
e
n
g
l
n
h
e
e
n
h
e
label
period
h
e
cell
scrape
wash
p
b
n
collect
cell
pellet
e
e
n
r
f
u
g
n
n
u
e
g
cell
pellet
glueosamin
label
h
v
infect
veio
ceil
p
r
e
p
r
e
previous
describ
briefli
p
c
k
e
cell
x
e
w
h
trishydrochlorid
p
n
homogen
g
h
fit
dounc
homogen
e
e
n
r
f
u
g
n
g
h
e
e
b
r
n
e
r
e
n
n
g
h
e
u
p
e
r
n
n
pellet
g
hour
pellet
e
b
r
n
e
suspend
g
l
e
n
e
n
h
buffer
p
h
n
centrifug
g
hour
final
h
e
w
h
e
e
b
r
n
e
suspend
g
l
e
n
e
n
h
buffer
c
n
n
n
g
per
cent
r
n
x
h
e
suspens
homogen
n
centrifug
g
hour
u
p
e
r
n
n
use
p
f
f
n
c
h
r
g
r
p
h
r
n
x
solubil
e
r
l
appli
column
diamet
w
h
l
h
p
coupl
sepharos
mb
pharmaeia
sweden
h
e
gel
equilibr
w
h
tri
buffer
salin
n
per
cent
r
n
x
f
n
develop
l
per
h
u
r
w
h
h
e
buffer
protein
specif
b
u
n
elut
w
h
galna
protein
w
h
w
h
u
affin
h
p
p
r
e
c
p
e
w
h
tca
n
w
h
e
order
c
n
c
e
n
r
e
elut
protein
wash
h
e
protein
dri
n
olofsson
et
al
solubil
buffer
react
specif
monoclon
antibodi
ad
optim
amount
antigenantibodi
complex
bound
fix
staphylococci
strain
cowani
immunopreeipit
wash
extens
p
b
supplement
per
cent
wv
sd
per
cent
vv
wash
buffer
supplement
protein
dissolv
disrupt
mixtur
sdspolyacrylamid
geleleetrophoresi
sdspolyacrylamid
geleleetrophoresi
done
accord
mors
et
al
separ
gel
percent
wv
acrylamid
crosslink
percent
wv
diatyltartardiamid
gel
stain
autoradiographi
done
k
k
x
r
p
x
c
r
film
desialyl
r
e
v
e
sialic
acid
h
v
glycoprotein
gc
without
affin
h
p
treat
amount
less
h
n
g
neuraminidas
unit
overnight
c
acet
buffer
pii
altern
aliquot
gc
without
affin
iipa
subject
r
e
e
n
c
hour
solut
neutral
solid
desalt
sephadex
gel
filtrat
alkalin
borohydrid
r
e
e
n
carri
previous
describ
fraction
h
p
chromatographi
materi
desalt
sephadex
dissolv
n
h
mixtur
incub
hour
room
e
p
e
r
u
r
e
c
nitrogen
tefloncap
tube
reaction
stop
ad
glacial
acet
acid
result
elimin
reaction
assay
sephadex
gel
filtrat
prepar
membran
protein
infect
vero
cell
subject
h
p
affin
chromatographi
fig
two
fraction
one
bound
without
affin
unbound
leetin
collect
hpa
bind
materi
elut
galnac
approxim
per
cent
hsv
glycoprotein
prepar
demonstr
affin
hpa
order
identifi
glycoprotein
present
fraction
immunoprecipit
monoclona
antibodi
direct
gagb
gc
gd
precipit
protein
subsequ
character
sdspolyacrylamid
gel
glycoprotein
affin
h
p
demonstr
gc
specif
fig
slot
higher
electrophoret
mobil
nonbind
gc
fig
slot
precursor
gc
also
identifi
presenc
glycoprotein
gagb
observ
fig
slot
glycoprotein
without
affin
h
p
contain
gagb
gc
gd
fig
slot
data
gd
shown
purif
gc
made
possibl
bind
extract
label
infect
cell
sepharos
immunosorb
column
contain
monoclon
antibodi
reactiv
gc
fig
materi
pass
column
design
pool
identifi
mixtur
gagb
gd
precursor
base
eleetrophoret
mobil
observ
pool
ie
specif
bound
protein
repres
per
cent
radioact
materi
load
column
identifi
gc
precursor
gc
two
addit
potypeptid
band
detect
correspond
protein
molecular
weight
k
k
fig
slot
lectin
affin
chromatographi
immunosorbentpurifi
gc
demonstr
per
cent
isol
gc
biospecif
bound
hpa
fig
unbound
hpabound
immunosorb
purifi
gc
subject
sdspage
two
polypeptid
band
affin
itpa
identifi
protein
electrophoret
mobil
significantli
higher
major
band
identifi
without
affin
leetin
fig
slot
data
togeth
present
fig
therefor
indic
among
hsv
glyeoprotein
ga
gb
gc
gd
two
subspeci
gc
affin
hpa
hpabind
subfract
compris
underglycosyl
precursor
gc
one
would
expect
nonbind
fraction
may
consist
sialyl
gteoprotein
mask
hpabind
oligosaccharid
remov
mask
structur
tte
gc
fraction
without
hpa
affin
treat
neuraminidas
dilut
hpa
chromatographi
fig
howev
per
cent
origin
hpa
neg
gc
fraction
becam
hpa
posit
treatment
neuraminidas
h
therefor
fraction
gc
without
affin
hpa
seem
contain
sialyl
glyeoprotein
gc
galna
penultim
sugar
autoradiographi
imag
immunosorb
purifi
glucosamin
label
gc
affin
ttpa
identifi
sd
polyaerylamid
gel
slot
total
extract
hefm
b
infect
cell
grown
c
slot
gc
isol
pool
w
p
column
without
purif
immunosorb
protein
precipit
monoeloanl
antibodi
gc
analog
fig
slot
slot
fraction
immunosorb
purifi
gc
could
bind
hpa
slot
immunosorb
purifi
gc
analog
fig
slot
notie
differ
electrophoreti
mobil
g
c
isol
immunosorb
chromatographi
slot
subpopul
gc
h
p
affin
mark
arrow
bind
gc
hpa
suggest
presenc
termin
galna
also
presenc
olink
oligosaccharid
find
subfraet
gc
contain
hpa
bind
activ
even
desialyl
rais
question
whether
subfract
primarili
bind
hpa
contain
ohgosaccharid
oglycosid
link
peptid
immunosorb
purifi
gc
therefor
fraction
hpa
affin
chromatographi
subfract
bind
hpa
subsequ
subject
treatment
alkalin
treatment
fraction
label
gc
studi
sephadex
untreat
mocktreat
materi
found
void
volum
exclus
panel
fig
treatment
alkalin
releas
label
materi
demonstr
molecular
weight
structur
correspond
result
interpret
elimin
olinkag
oligosaccharid
peptid
gc
experi
pronasedigest
underglycosyl
hsv
glycoprotein
produc
presenc
tunieamycin
indic
exist
least
two
class
rel
larg
tunicamycinresist
oligosaccharid
without
affin
hpa
onofsso
et
al
submit
public
data
support
conclus
one
type
olink
sugar
may
attach
hsv
glycoprotein
oligosaceharid
nglycosid
linkag
high
mannos
type
moder
branch
complex
type
exhibit
affin
con
test
hpa
bind
nonbind
fraction
gc
con
affin
chromatographi
reveal
approxim
abund
biospecif
bind
gc
fraction
con
fig
data
indic
nglycosidi
link
viral
glycoprotein
gagb
gc
gd
synthes
infect
cell
glycosyl
sever
discret
step
found
typespecif
glyeoprotein
gc
contain
oligosaccharid
bind
hpa
lectin
specif
affin
galnac
sugar
generaili
absent
normal
nglycosid
oligosaccharid
present
oligosaccharid
link
oglycosid
serin
threonin
residu
poiypeptid
recent
find
glycoprotein
gc
sensit
weak
alkalin
borohydrid
treatment
contain
tm
resist
oligosaccharid
olosso
et
al
submit
public
support
gc
addit
nglycosid
carbohydr
chain
contain
oglycosid
link
oligosaccharid
present
studi
immunochem
specif
hsv
glycoprotein
without
affin
hpa
affin
lectin
identifi
immunoprecipit
monoclon
antibodi
hsv
specifi
glyeoprotein
glycoprotcin
without
affin
hpa
contain
gagb
gd
major
gc
wherea
glycoprotein
immunolog
specif
gc
found
fraction
bind
hpa
data
thu
emphas
hsvglycoprotein
gc
contain
oligosaccharid
affin
hpa
use
immunosorbentpurifi
glycoprotein
could
clearli
demonstr
glyeoprotein
hpabind
oligosaccharid
constitut
subfract
compris
per
cent
glycosylatcd
gc
popul
fig
howev
data
also
show
gc
without
affin
hpa
contain
olink
carbohydr
oglycosid
well
nglycosid
linkag
exist
one
gc
molecul
fig
eleetrophoret
analysi
hpabind
gc
subfract
reveal
two
polypeptid
one
molecular
weight
k
correspond
partial
glycosyl
precursor
gc
pgc
one
molecular
weight
k
intermedi
fulli
glycosyl
gc
pgc
low
molecular
weight
hpabind
gc
molecul
rel
bulk
glyeoprotein
gc
specif
suggest
gc
affin
hpa
constitut
partial
glycosyl
gc
intermedi
assum
hpabind
oligosaecharid
repres
precursor
larger
oglycosid
ohgosaccharid
lack
hpaaffin
might
suspect
hpabind
site
block
termin
sialic
acid
observ
hpabind
oligosaccharid
lymphoeyt
howev
experi
two
differ
procedur
elimin
sialic
acid
margin
increas
hpabind
activ
gc
suggest
sialyl
hpabind
site
main
reason
absenc
hpa
bind
propert
i
hpabind
glycoprotein
might
therefor
repres
fulli
glycosyl
fraction
gc
glycosyl
differ
bulk
gc
one
possibl
explan
would
biosynthesi
gcassoci
oglycosid
oligosaecharid
point
branch
follow
differ
pathway
one
lead
hpabind
oligosaccharid
oligosaceharid
termin
structur
properti
without
affin
hpa
divers
caus
either
sole
host
cell
glyeosyl
transferas
one
viru
specifi
viru
modifi
enzym
act
concert
cell
specifi
glycosyl
transferas
previous
point
chang
kinet
properti
glyeosyl
transferas
hsv
infect
cell
presenc
compet
glycosyl
transferas
lead
biosynthet
branch
core
structur
differ
type
otigosaccharid
without
blood
group
activ
demonstr
carbohydr
sheep
submaxillari
mucin
presenc
tm
trace
amount
glycoprotcin
gagb
gc
demonstr
surfac
infect
cell
shown
iodin
intact
cell
indirect
immunofluoresc
monoclon
ab
fix
cell
unpublish
data
fact
gc
glycoprotein
transport
insert
plasmamembran
signific
amount
presenc
tm
gc
expos
cell
surfac
lack
reactiv
antibodydepend
cellmedi
c
otox
test
find
suggest
presenc
nglycosid
oligosaccharid
essenti
adcc
reaction
hand
presenc
carbohydr
seem
suffici
transport
glycoprotcin
plasmamembran
differ
function
two
class
oligosaccharidc
itsv
glycoprotcin
gc
might
thu
discern
